Arizona State Retirement System Cara Therapeutics, Inc. Transaction History

Arizona State Retirement System

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$4.89 - $12.27 $1,701 - $4,269	348 Added 2.7%	13,234 $64,000
Q4 2022 Feb 07, 2023	BUY	$8.88 - $12.77 $4,502 - $6,474	507 Added 4.1%	12,886 $138,000
Q3 2022 Nov 07, 2022	BUY	$8.24 - $12.56 $1,400 - $2,135	170 Added 1.39%	12,379 $116,000
Q2 2022 Jul 28, 2022	BUY	$7.45 - $13.84 $4,827 - $8,968	648 Added 5.61%	12,209 $111,000
Q1 2022 May 04, 2022	BUY	$9.94 - $12.65 $7,713 - $9,816	776 Added 7.2%	11,561 $140,000
Q4 2021 Feb 04, 2022	SELL	$11.99 - $18.14 $1,462 - $2,213	-122 Reduced 1.12%	10,785 $131,000
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $704 - $979	61 Added 0.56%	10,907 $169,000
Q2 2021 Aug 02, 2021	SELL	$12.38 - $29.19 $36,335 - $85,672	-2,935 Reduced 21.3%	10,846 $155,000
Q1 2021 May 06, 2021	BUY	$15.07 - $21.71 $13,156 - $18,952	873 Added 6.76%	13,781 $299,000
Q4 2020 Jan 28, 2021	SELL	$12.72 - $16.16 $6,436 - $8,176	-506 Reduced 3.77%	12,908 $195,000
Q3 2020 Nov 05, 2020	BUY	$12.34 - $17.92 $42,017 - $61,017	3,405 Added 34.02%	13,414 $171,000
Q2 2020 Aug 04, 2020	BUY	$12.39 - $17.33 $124,011 - $173,455	10,009 New	10,009 $171,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.